Jazz Pharmaceuticals JAZZ Income Taxes Payable
Income Taxes Payable at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:TaxesPayableCurrent.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's income taxes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's income taxes payable?
- Jazz Pharmaceuticals (JAZZ) reported income taxes payable of $93.7M in Q1 2026.
- How has Jazz Pharmaceuticals's income taxes payable changed year-over-year?
- Jazz Pharmaceuticals's income taxes payable increased by 195.0% year-over-year, from $31.76M to $93.7M.
- What is the long-term trend for Jazz Pharmaceuticals's income taxes payable?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's income taxes payable has grown at a 17.4% compound annual growth rate (CAGR), from $25.2M to $56.3M.
- What does income taxes payable mean?
- The amount of income tax currently owed to tax authorities.
- How do you interpret income taxes payable?
- Fluctuations generally track changes in profitability and the timing of tax installments.
- How does income taxes payable compare across companies?
- Highly dependent on the company's effective tax rate and jurisdictional tax laws compared to peers.